Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
Kang et al., 2018), it is possible that the BPC 157 therapeutic effect may also be related to improvements in abdominal wall compliance
Its legal to buy, hold and use as a research chemical for in-vitro laboratory work, and thats the only use we supply it for
FIGURE 3 FIGURE 4 FIGURE 5 BPC 157 retrobulbar application was given as therapy after L-NAME at 20 min or at 48 h, as early therapy (i.e., after L-NAME at 20 min), or as delayed therapy (after L-NAME at 48 h)
Hunnicutt, R
